-
September 27: The Week in Cancer News
Adding MRI to prostate screening can help limit overdiagnosis, and breast cancer patients who smoke have a higher risk of radiotherapy-related lung cancer.
by Eric Fitzsimmons
-
September 20: The Week in Cancer News
The AACR spotlights cancer advances and challenges in new report, and the FDA approves second CDK 4/6 inhibitor to reduce risk of recurrence in early-stage breast cancer.
by Marci A. Landsmann
-
September 13: The Week in Cancer News
Mammogram findings will now include information about breast density, and youth vaping is on the decline.
by Kevin McLaughlin
-
September 6: The Week in Cancer News
Asian American and Pacific Islander women experience rising breast cancer incidence, and a study finds most people diagnosed with cancer will experience cognitive symptoms.
by Thomas Celona
-
August 30: The Week in Cancer News
Access to high-quality hospitals may be affected by insurance type, and the proliferation of digital tools could increase burdens on patients.
by Eric Fitzsimmons
-
August 23: The Week in Cancer News
Early immunotherapy may make more liver cancer patients eligible for surgery, and the FDA approves a new use for a lung cancer treatment.
by Kevin McLaughlin
-
August 16: The Week in Cancer News
Even small amounts of alcohol can increase cancer mortality risk, and research explores the role of weight-loss drugs in preventing cancer.
by Marci A. Landsmann
-
August 9: The Week in Cancer News
More endometrial cancer patients can now receive an immunotherapy, and taking aspirin regularly may help some people reduce their risk for colorectal cancer.
by Thomas Celona
-
August 2: The Week in Cancer News
Blood test approval widens access to colorectal cancer screening option, and language barriers interrupt cancer care before it starts.
by Eric Fitzsimmons
-
July 26: The Week in Cancer News
Double mastectomy doesn’t lead to a survival advantage over lumpectomy or single mastectomy, and research explores hearing loss linked to cisplatin.
by Marci A. Landsmann
Cancer Talk
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore